<?xml version="1.0" encoding="UTF-8" standalone="no"?><document id="DDI-DrugBank.d115">
    <sentence id="DDI-DrugBank.d115.s0" text="Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, erythromycin, clarithromycin).">
        <entity charOffset="21-28" id="DDI-DrugBank.d115.s0.e0" text="imatinib" type="drug"/>
        <entity charOffset="76-83" id="DDI-DrugBank.d115.s0.e1" text="imatinib" type="drug"/>
        <entity charOffset="150-156" id="DDI-DrugBank.d115.s0.e2" text="Gleevec" type="brand"/>
        <entity charOffset="202-213" id="DDI-DrugBank.d115.s0.e3" text="ketoconazole" type="drug"/>
        <entity charOffset="216-227" id="DDI-DrugBank.d115.s0.e4" text="itraconazole" type="drug"/>
        <entity charOffset="230-241" id="DDI-DrugBank.d115.s0.e5" text="erythromycin" type="drug"/>
        <entity charOffset="244-257" id="DDI-DrugBank.d115.s0.e6" text="clarithromycin" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d115.s0.e0" e2="DDI-DrugBank.d115.s0.e1" id="DDI-DrugBank.d115.s0.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d115.s0.e0" e2="DDI-DrugBank.d115.s0.e2" id="DDI-DrugBank.d115.s0.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d115.s0.e0" e2="DDI-DrugBank.d115.s0.e3" id="DDI-DrugBank.d115.s0.p2"/>
        <pair ddi="false" e1="DDI-DrugBank.d115.s0.e0" e2="DDI-DrugBank.d115.s0.e4" id="DDI-DrugBank.d115.s0.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d115.s0.e0" e2="DDI-DrugBank.d115.s0.e5" id="DDI-DrugBank.d115.s0.p4"/>
        <pair ddi="false" e1="DDI-DrugBank.d115.s0.e0" e2="DDI-DrugBank.d115.s0.e6" id="DDI-DrugBank.d115.s0.p5"/>
        <pair ddi="false" e1="DDI-DrugBank.d115.s0.e1" e2="DDI-DrugBank.d115.s0.e2" id="DDI-DrugBank.d115.s0.p6"/>
        <pair ddi="false" e1="DDI-DrugBank.d115.s0.e1" e2="DDI-DrugBank.d115.s0.e3" id="DDI-DrugBank.d115.s0.p7"/>
        <pair ddi="false" e1="DDI-DrugBank.d115.s0.e1" e2="DDI-DrugBank.d115.s0.e4" id="DDI-DrugBank.d115.s0.p8"/>
        <pair ddi="false" e1="DDI-DrugBank.d115.s0.e1" e2="DDI-DrugBank.d115.s0.e5" id="DDI-DrugBank.d115.s0.p9"/>
        <pair ddi="false" e1="DDI-DrugBank.d115.s0.e1" e2="DDI-DrugBank.d115.s0.e6" id="DDI-DrugBank.d115.s0.p10"/>
        <pair ddi="true" e1="DDI-DrugBank.d115.s0.e2" e2="DDI-DrugBank.d115.s0.e3" id="DDI-DrugBank.d115.s0.p11" type="advise"/>
        <pair ddi="true" e1="DDI-DrugBank.d115.s0.e2" e2="DDI-DrugBank.d115.s0.e4" id="DDI-DrugBank.d115.s0.p12" type="advise"/>
        <pair ddi="true" e1="DDI-DrugBank.d115.s0.e2" e2="DDI-DrugBank.d115.s0.e5" id="DDI-DrugBank.d115.s0.p13" type="advise"/>
        <pair ddi="true" e1="DDI-DrugBank.d115.s0.e2" e2="DDI-DrugBank.d115.s0.e6" id="DDI-DrugBank.d115.s0.p14" type="advise"/>
        <pair ddi="false" e1="DDI-DrugBank.d115.s0.e3" e2="DDI-DrugBank.d115.s0.e4" id="DDI-DrugBank.d115.s0.p15"/>
        <pair ddi="false" e1="DDI-DrugBank.d115.s0.e3" e2="DDI-DrugBank.d115.s0.e5" id="DDI-DrugBank.d115.s0.p16"/>
        <pair ddi="false" e1="DDI-DrugBank.d115.s0.e3" e2="DDI-DrugBank.d115.s0.e6" id="DDI-DrugBank.d115.s0.p17"/>
        <pair ddi="false" e1="DDI-DrugBank.d115.s0.e4" e2="DDI-DrugBank.d115.s0.e5" id="DDI-DrugBank.d115.s0.p18"/>
        <pair ddi="false" e1="DDI-DrugBank.d115.s0.e4" e2="DDI-DrugBank.d115.s0.e6" id="DDI-DrugBank.d115.s0.p19"/>
        <pair ddi="false" e1="DDI-DrugBank.d115.s0.e5" e2="DDI-DrugBank.d115.s0.e6" id="DDI-DrugBank.d115.s0.p20"/>
    </sentence>
    <sentence id="DDI-DrugBank.d115.s1" text="Substances that inhibit the cytochrome P450 isoenzyme (CYP3A4) activity may decrease metabolism and increase imatinib concentrations.">
        <entity charOffset="109-116" id="DDI-DrugBank.d115.s1.e0" text="imatinib" type="drug"/>
    </sentence>
    <sentence id="DDI-DrugBank.d115.s2" text="There is a significant increase in exposure to imatinib when Gleevec is coadministered with ketoconazole (CYP3A4 inhibitor).">
        <entity charOffset="47-54" id="DDI-DrugBank.d115.s2.e0" text="imatinib" type="drug"/>
        <entity charOffset="61-67" id="DDI-DrugBank.d115.s2.e1" text="Gleevec" type="brand"/>
        <entity charOffset="92-103" id="DDI-DrugBank.d115.s2.e2" text="ketoconazole" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d115.s2.e0" e2="DDI-DrugBank.d115.s2.e1" id="DDI-DrugBank.d115.s2.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d115.s2.e0" e2="DDI-DrugBank.d115.s2.e2" id="DDI-DrugBank.d115.s2.p1"/>
        <pair ddi="true" e1="DDI-DrugBank.d115.s2.e1" e2="DDI-DrugBank.d115.s2.e2" id="DDI-DrugBank.d115.s2.p2" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d115.s3" text="Drugs that may decrease imatinib plasma concentrations: Substances that are inducers of CYP3A4 activity may increase metabolism and decrease imatinib plasma concentrations.">
        <entity charOffset="24-31" id="DDI-DrugBank.d115.s3.e0" text="imatinib" type="drug"/>
        <entity charOffset="141-148" id="DDI-DrugBank.d115.s3.e1" text="imatinib" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d115.s3.e0" e2="DDI-DrugBank.d115.s3.e1" id="DDI-DrugBank.d115.s3.p0"/>
    </sentence>
    <sentence id="DDI-DrugBank.d115.s4" text="Co-medications that induce CYP3A4 (e.g., dexamethasone, phenytoin, carbamazepine, rifampin, phenobarbital or St.">
        <entity charOffset="41-53" id="DDI-DrugBank.d115.s4.e0" text="dexamethasone" type="drug"/>
        <entity charOffset="56-64" id="DDI-DrugBank.d115.s4.e1" text="phenytoin" type="drug"/>
        <entity charOffset="67-79" id="DDI-DrugBank.d115.s4.e2" text="carbamazepine" type="drug"/>
        <entity charOffset="82-89" id="DDI-DrugBank.d115.s4.e3" text="rifampin" type="drug"/>
        <entity charOffset="92-104" id="DDI-DrugBank.d115.s4.e4" text="phenobarbital" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d115.s4.e0" e2="DDI-DrugBank.d115.s4.e1" id="DDI-DrugBank.d115.s4.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d115.s4.e0" e2="DDI-DrugBank.d115.s4.e2" id="DDI-DrugBank.d115.s4.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d115.s4.e0" e2="DDI-DrugBank.d115.s4.e3" id="DDI-DrugBank.d115.s4.p2"/>
        <pair ddi="false" e1="DDI-DrugBank.d115.s4.e0" e2="DDI-DrugBank.d115.s4.e4" id="DDI-DrugBank.d115.s4.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d115.s4.e1" e2="DDI-DrugBank.d115.s4.e2" id="DDI-DrugBank.d115.s4.p4"/>
        <pair ddi="false" e1="DDI-DrugBank.d115.s4.e1" e2="DDI-DrugBank.d115.s4.e3" id="DDI-DrugBank.d115.s4.p5"/>
        <pair ddi="false" e1="DDI-DrugBank.d115.s4.e1" e2="DDI-DrugBank.d115.s4.e4" id="DDI-DrugBank.d115.s4.p6"/>
        <pair ddi="false" e1="DDI-DrugBank.d115.s4.e2" e2="DDI-DrugBank.d115.s4.e3" id="DDI-DrugBank.d115.s4.p7"/>
        <pair ddi="false" e1="DDI-DrugBank.d115.s4.e2" e2="DDI-DrugBank.d115.s4.e4" id="DDI-DrugBank.d115.s4.p8"/>
        <pair ddi="false" e1="DDI-DrugBank.d115.s4.e3" e2="DDI-DrugBank.d115.s4.e4" id="DDI-DrugBank.d115.s4.p9"/>
    </sentence>
    <sentence id="DDI-DrugBank.d115.s5" text="Johns Wort) may significantly reduce exposure to Gleevec.">
        <entity charOffset="49-55" id="DDI-DrugBank.d115.s5.e0" text="Gleevec" type="brand"/>
    </sentence>
    <sentence id="DDI-DrugBank.d115.s6" text="Pretreatment of healthy volunteers with multiple doses of rifampin followed by a single dose of Gleevec, increased Gleevec oral-dose clearance by 3.8-fold, which significantly (p 0.05) decreased mean cmax and AUC(0-8).">
        <entity charOffset="58-65" id="DDI-DrugBank.d115.s6.e0" text="rifampin" type="drug"/>
        <entity charOffset="96-102" id="DDI-DrugBank.d115.s6.e1" text="Gleevec" type="brand"/>
        <entity charOffset="115-121" id="DDI-DrugBank.d115.s6.e2" text="Gleevec" type="brand"/>
        <pair ddi="true" e1="DDI-DrugBank.d115.s6.e0" e2="DDI-DrugBank.d115.s6.e1" id="DDI-DrugBank.d115.s6.p0" type="mechanism"/>
        <pair ddi="false" e1="DDI-DrugBank.d115.s6.e0" e2="DDI-DrugBank.d115.s6.e2" id="DDI-DrugBank.d115.s6.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d115.s6.e1" e2="DDI-DrugBank.d115.s6.e2" id="DDI-DrugBank.d115.s6.p2"/>
    </sentence>
    <sentence id="DDI-DrugBank.d115.s7" text="In patients where rifampin or other CYP3A4 inducers are indicated, alternative therapeutic agents with less enzyme induction potential should be considered.">
        <entity charOffset="18-25" id="DDI-DrugBank.d115.s7.e0" text="rifampin" type="drug"/>
    </sentence>
    <sentence id="DDI-DrugBank.d115.s8" text="Drugs that may have their plasma concentration altered by Gleevec Gleevec increases the mean cmax and AUC of simvastatin (CYP3A4 substrate) 2- and 3.5-fold, respectively, suggesting an inhibition of the CYP3A4 by Gleevec.">
        <entity charOffset="58-64" id="DDI-DrugBank.d115.s8.e0" text="Gleevec" type="brand"/>
        <entity charOffset="66-72" id="DDI-DrugBank.d115.s8.e1" text="Gleevec" type="brand"/>
        <entity charOffset="109-119" id="DDI-DrugBank.d115.s8.e2" text="simvastatin" type="drug"/>
        <entity charOffset="213-219" id="DDI-DrugBank.d115.s8.e3" text="Gleevec" type="brand"/>
        <pair ddi="false" e1="DDI-DrugBank.d115.s8.e0" e2="DDI-DrugBank.d115.s8.e1" id="DDI-DrugBank.d115.s8.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d115.s8.e0" e2="DDI-DrugBank.d115.s8.e2" id="DDI-DrugBank.d115.s8.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d115.s8.e0" e2="DDI-DrugBank.d115.s8.e3" id="DDI-DrugBank.d115.s8.p2"/>
        <pair ddi="true" e1="DDI-DrugBank.d115.s8.e1" e2="DDI-DrugBank.d115.s8.e2" id="DDI-DrugBank.d115.s8.p3" type="mechanism"/>
        <pair ddi="false" e1="DDI-DrugBank.d115.s8.e1" e2="DDI-DrugBank.d115.s8.e3" id="DDI-DrugBank.d115.s8.p4"/>
        <pair ddi="false" e1="DDI-DrugBank.d115.s8.e2" e2="DDI-DrugBank.d115.s8.e3" id="DDI-DrugBank.d115.s8.p5"/>
    </sentence>
    <sentence id="DDI-DrugBank.d115.s9" text="Particular caution is recommended when administering Gleevec with CYP3A4 substrates that have a narrow therapeutic window (e.g., cyclosporine or pimozide).">
        <entity charOffset="53-59" id="DDI-DrugBank.d115.s9.e0" text="Gleevec" type="brand"/>
        <entity charOffset="129-140" id="DDI-DrugBank.d115.s9.e1" text="cyclosporine" type="drug"/>
        <entity charOffset="145-152" id="DDI-DrugBank.d115.s9.e2" text="pimozide" type="drug"/>
        <pair ddi="true" e1="DDI-DrugBank.d115.s9.e0" e2="DDI-DrugBank.d115.s9.e1" id="DDI-DrugBank.d115.s9.p0" type="advise"/>
        <pair ddi="true" e1="DDI-DrugBank.d115.s9.e0" e2="DDI-DrugBank.d115.s9.e2" id="DDI-DrugBank.d115.s9.p1" type="advise"/>
        <pair ddi="false" e1="DDI-DrugBank.d115.s9.e1" e2="DDI-DrugBank.d115.s9.e2" id="DDI-DrugBank.d115.s9.p2"/>
    </sentence>
    <sentence id="DDI-DrugBank.d115.s10" text="Gleevec will increase plasmaconcentration of other CYP3A4 metabolized drugs (e.g., triazolo-benzodiazepines, dihydropyridine calcium channel blockers, certain HMG-CoA reductase inhibitors, etc.).">
        <entity charOffset="0-6" id="DDI-DrugBank.d115.s10.e0" text="Gleevec" type="brand"/>
        <entity charOffset="92-106" id="DDI-DrugBank.d115.s10.e1" text="benzodiazepines" type="group"/>
        <entity charOffset="109-148" id="DDI-DrugBank.d115.s10.e2" text="dihydropyridine calcium channel blockers" type="group"/>
        <entity charOffset="159-186" id="DDI-DrugBank.d115.s10.e3" text="HMG-CoA reductase inhibitors" type="group"/>
        <pair ddi="true" e1="DDI-DrugBank.d115.s10.e0" e2="DDI-DrugBank.d115.s10.e1" id="DDI-DrugBank.d115.s10.p0" type="mechanism"/>
        <pair ddi="true" e1="DDI-DrugBank.d115.s10.e0" e2="DDI-DrugBank.d115.s10.e2" id="DDI-DrugBank.d115.s10.p1" type="mechanism"/>
        <pair ddi="true" e1="DDI-DrugBank.d115.s10.e0" e2="DDI-DrugBank.d115.s10.e3" id="DDI-DrugBank.d115.s10.p2" type="mechanism"/>
        <pair ddi="false" e1="DDI-DrugBank.d115.s10.e1" e2="DDI-DrugBank.d115.s10.e2" id="DDI-DrugBank.d115.s10.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d115.s10.e1" e2="DDI-DrugBank.d115.s10.e3" id="DDI-DrugBank.d115.s10.p4"/>
        <pair ddi="false" e1="DDI-DrugBank.d115.s10.e2" e2="DDI-DrugBank.d115.s10.e3" id="DDI-DrugBank.d115.s10.p5"/>
    </sentence>
    <sentence id="DDI-DrugBank.d115.s11" text="Because warfarin is metabolized by CYP2C9 and CYP3A4, patients who require anticoagulation should receive low-molecular weight or standard heparin.">
        <entity charOffset="8-15" id="DDI-DrugBank.d115.s11.e0" text="warfarin" type="drug"/>
        <entity charOffset="139-145" id="DDI-DrugBank.d115.s11.e1" text="heparin" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d115.s11.e0" e2="DDI-DrugBank.d115.s11.e1" id="DDI-DrugBank.d115.s11.p0"/>
    </sentence>
    <sentence id="DDI-DrugBank.d115.s12" text="in vitro, Gleevec inhibits the cytochrome P450 isoenzyme CYP2D6 activity at similar concentrations that affect CYP3A4 activity.">
        <entity charOffset="10-16" id="DDI-DrugBank.d115.s12.e0" text="Gleevec" type="brand"/>
    </sentence>
    <sentence id="DDI-DrugBank.d115.s13" text="Systemic exposure to substrates of CYP2D6 is expected to be increased when coadministered with Gleevec."/>
    <sentence id="DDI-DrugBank.d115.s14" text="No specific studies have been performed and caution is recommended."><negationtags>&lt;scope&gt; &lt;cue&gt; No &lt;/cue&gt; specific studies have been performed and caution is recommended. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d115.s15" text="in vitro, Gleevec inhibits acetaminophen O-glucuronidation (Ki value of 58.5  M) at therapeutic levels.">
        <entity charOffset="10-16" id="DDI-DrugBank.d115.s15.e0" text="Gleevec" type="brand"/>
    </sentence>
    <sentence id="DDI-DrugBank.d115.s16" text="Systemic exposure to acetaminophen is expected to be increased when coadministered with Gleevec.">
        <entity charOffset="21-33" id="DDI-DrugBank.d115.s16.e0" text="acetaminophen" type="drug"/>
        <entity charOffset="88-94" id="DDI-DrugBank.d115.s16.e1" text="Gleevec" type="brand"/>
        <pair ddi="true" e1="DDI-DrugBank.d115.s16.e0" e2="DDI-DrugBank.d115.s16.e1" id="DDI-DrugBank.d115.s16.p0" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d115.s17" text="No specific studies in humans have been performed and caution is recommended."><negationtags>&lt;scope&gt; &lt;cue&gt; No &lt;/cue&gt; specific studies in humans have been performed and caution is recommended. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d115.s18" text=""/>
</document>